Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3234443
Max Phase: Preclinical
Molecular Formula: C40H59N6O9+
Molecular Weight: 767.95
Molecule Type: Small molecule
Associated Items:
ID: ALA3234443
Max Phase: Preclinical
Molecular Formula: C40H59N6O9+
Molecular Weight: 767.95
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COC(=O)c1ccc(C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCC[N+](C)(C)C)C(=O)NC(CO)CO)C2CCCC2)cc1
Standard InChI: InChI=1S/C40H58N6O9/c1-26(41-38(52)33(23-27-13-7-6-8-14-27)44-36(50)29-18-20-30(21-19-29)40(54)55-5)35(49)45-34(28-15-9-10-16-28)39(53)43-32(17-11-12-22-46(2,3)4)37(51)42-31(24-47)25-48/h6-8,13-14,18-21,26,28,31-34,47-48H,9-12,15-17,22-25H2,1-5H3,(H4-,41,42,43,44,45,49,50,51,52,53)/p+1/t26-,32-,33-,34-/m0/s1
Standard InChI Key: RVSBUVWESBGOMR-OPPLUPLLSA-O
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 767.95 | Molecular Weight (Monoisotopic): 767.4338 | AlogP: 0.82 | #Rotatable Bonds: 21 |
Polar Surface Area: 212.26 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 7 |
#RO5 Violations: 2 | HBA (Lipinski): 15 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.70 | CX Basic pKa: | CX LogP: -2.92 | CX LogD: -2.92 |
Aromatic Rings: 2 | Heavy Atoms: 55 | QED Weighted: 0.05 | Np Likeness Score: 0.04 |
1. Simhadri C, Daze KD, Douglas SF, Quon TT, Dev A, Gignac MC, Peng F, Heller M, Boulanger MJ, Wulff JE, Hof F.. (2014) Chromodomain antagonists that target the polycomb-group methyllysine reader protein chromobox homolog 7 (CBX7)., 57 (7): [PMID:24625057] [10.1021/jm401487x] |
Source(1):